21 results
S-8
SLRN
Acelyrin Inc
28 Mar 24
Registration of securities for employees
4:43pm
for liabilities, including reimbursement for expenses incurred, arising under the Securities Act of 1933, as amended (the “Securities Act”). The Registrant’s
10-K
2023 FY
SLRN
Acelyrin Inc
28 Mar 24
Annual report
4:21pm
and reimbursement of izokibep, lonigutamab or any other product candidates we may develop, if approved;
our continued reliance on third parties to conduct … regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain
8-K
EX-10.1
2i3l4yml9 rxaa
2 Aug 23
Departure of Directors or Certain Officers
5:05pm
10-Q
5pfkzvts2
15 Jun 23
Quarterly report
4:19pm
8-K
EX-3.2
ggpoe2
9 May 23
ACELYRIN, INC. Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
4:16pm
S-8
8k3x8jwots6 c4ow
8 May 23
Registration of securities for employees
5:27pm
424B4
z8vgzgcscf7i ymtn
5 May 23
Prospectus supplement with pricing info
4:22pm
S-1/A
EX-10.11
zz3fh51zc 7fo789kv
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-10.10
aqx 4wn8ec7w
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-3.4
88uxlvjtzlo 0aco2
1 May 23
IPO registration (amended)
6:10am
S-1/A
4b71o2q
1 May 23
IPO registration (amended)
6:10am
S-1
dcnl 9bsjonhek
13 Apr 23
IPO registration
5:10pm
S-1
EX-3.1
85imx7l
13 Apr 23
IPO registration
5:10pm
S-1
EX-10.1
55od ibk6r
13 Apr 23
IPO registration
5:10pm
S-1
EX-10.13
3kijwd32l vgun
13 Apr 23
IPO registration
5:10pm
S-1
EX-10.12
v39zcupj21
13 Apr 23
IPO registration
5:10pm